🟢 Structure Therapeutics is trading at 4.3% up in pre-market as biotech sentiment strengthens

Structure Therapeutics is trading up 4.3% now at $37.50, with the move appearing mainly linked to stronger biotechnology sentiment.

• Shares rebounded from the September 23 close of $35.95.
• No fresh company-specific announcement or earnings catalyst was identified for September 24; XBI was up 2.61% pre-market despite weaker broad-market conditions.
• Recent oral obesity-pipeline data remain supportive but were reported earlier in September, not overnight.